Related Experiment Video
Updated: Aug 6, 2026
08:12
Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells
Published on: August 12, 2014
Apoptosis and cutaneous T cell lymphoma
1Department of Therapeutic Radiology and Dermatology, Yale University School of Medicine, New Haven, Connecticut 06520, USA. barry.kacinski@yale.edu
Annals of the New York Academy of Sciences
|October 12, 2001
Summary
Cutaneous T cell lymphoma (CTCL) therapies induce T cell apoptosis, but malignant T cells resist systemic chemotherapy. Understanding these defects can improve CTCL treatments.
Area of Science:
- Oncology
- Immunology
- Dermatology
Background:
- Cutaneous T cell lymphoma (CTCL) is a malignancy of T lymphocytes.
- Current successful CTCL therapies induce T cell apoptosis.
- Malignant T cells in CTCL exhibit resistance to systemic chemotherapy, unlike B cell lymphomas.
Purpose of the Study:
- To investigate the differential apoptotic responses of malignant T cells to various therapies.
- To elucidate the molecular mechanisms underlying T cell apoptosis resistance in CTCL.
- To identify potential targets for improving CTCL treatment strategies.
Main Methods:
- Review of existing literature on CTCL therapies and T cell apoptosis.
- Analysis of the mechanisms of action for localized X-ray therapy, UV light therapy, topical chemotherapy, and systemic chemotherapy.
- Comparison of apoptotic responses in neoplastic vs. non-neoplastic T cells.
Main Results:
- Localized therapies (X-ray, UV, topical) effectively induce apoptosis in malignant T cells.
- Systemic chemotherapeutic agents show limited efficacy in inducing apoptosis in CTCL T cells.
- Neoplastic T cells in CTCL possess defects in apoptotic control mechanisms.
Conclusions:
- CTCL T cells have impaired apoptosis regulation, necessitating potent pro-apoptotic signals from therapies like radiation.
- Understanding the molecular basis of this resistance is crucial for developing novel and more effective CTCL treatments.
- Targeting apoptosis pathways offers a promising avenue for future therapeutic interventions in CTCL.
More Related Videos
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
Related Concept Videos
01:30Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:17Phagocytosis of Apoptotic Cells
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...